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Figure S1. Optimization of the concentration of PMA and ionomycin to detect IFN-, IL-17, and CXCL13. 
CD4+ T cells from rheumatoid synovitis were stimulated with PMA and ionomycin at the indicated 
concentrations for 5 h and then analyzed by flow cytometry. Numbers in the quadrants represent the 






Figure S2. Flow cytometric analysis of synovial tissues including large cells. The CXCL13 production by 
single cells of RA synovial tissue without PMA–ionomycin stimulation was analyzed (n=14). A 
representative dot plot gated on cells including larger cells than lymphocytes is shown. Numbers in the 






Figure S3. Spontaneous CXCL13 production in synovial tissue (ST) and synovial fluid mononuclear cells 
(SFMC) of RA. CD4+ T cells from ST or SFMC of RA were analyzed by flow cytometry without 
PMA–ionomycin stimulation (n=3). Numbers indicate percentage of indicated populations in CD4+ T cells. 






Figure S4. Spontaneous CXCL13 production by blood and synovial CD4+ T cells from RA patients. CD4+ T 
cells were sorted with magnetic beads and then cultured with complete RPMI 1640 medium at a 
concentration of 1106 /ml for 36 h at 37°C. The concentration of CXCL13 in the supernatant or synovial 
fluid was measured by ELISA (left; ST: n=1, SF: n=3). The expression of mRNA in sorted CD4+ T cells was 
quantified by qPCR using TaqMan Gene Expression Assay (Applied Biosystems); CXCL13 
(Hs00757930_m1) and GAPDH (Hs02758991_g1). The expression of CXCL13 was normalized to the 







Figure S5. CXCL13+CD4+ T cells of RA synovitis are restricted to effector memory helper T cells. 
Spontaneous CXCL13 production by CCR7+CD45RA+ naïve cells, CCR7+CD45RA− central memory (Tcm) 
cells, and CCR7−CD45RA− effector memory (Tem) CD4+ T cells is shown. Numbers in quadrants and 
histograms show percentages of the indicated populations. Representative data from three independent 






Figure S6. The summaries of the time course for the production of CXCL13 and IFN-γ in three RA patients. 
Sorted whole CD4+ T cells with low spontaneous production of CXCL13 from RA synovitis were cultures as 
in Figure 4B. Closed symbols with solid line and open symbols with dashed line indicate cells cultured with 




Figure S7. Relevance between RA clinical parameters and iTh13 cells. The frequencies of 
CXCL13+CD4+ T cells among CD4+ T cells in patient with low ESR ( <30; ST: n=10, SF: n=2), high 
ESR ( ≥30; ST: n=10, SF: n=2), negative rheumatoid factor (RF) (ST: n=2, SF: n=2), positive RF (ST: 
n=18, SF: n=2), low disease activity (DAS28<3.2; ST: n=4), and moderate or high disease activity 









































































Table S1. Clinical details of patients with RA 
 
 
Number of patients 24 
 
Sex, male/female 7/17 
 
Age  65.1 ± 10.5 
 
Disease duration (y) 13.5 ± 9.24 
 
Positive ACPA, n (%) 22 (91.7) 
 
ESR (mm) 37.9 ± 37.0 
 
C-reactive protein (mg/l) 1.59 ± 1.61 
 
DAS28(ESR) 4.48 ± 1.27 
 
Drug use, n (%) 22 (91.7%) 
 
     DMARDs 19 (79.2%) 
 
     Steroid 13 (51.2%) 
       Biologics 3 (12.5%) 
 
SD = standard deviation; ACPA = anti-citrullinated protein 
antibody; ESR = erythrocyte sedimentation ratio; DAS28 = 











Table S2.  Anti-human antibodies used in this study 
 
          
Antigen Manufacturer Clone Format Application 
CD3 BioLegend UCTH1 Brilliant Violet Flow cytometry 
CD3 BioLegend UCTH1 PE Immunohistofluorescence 
CD4 BioLegend RPA-T4 PerCP-Cy5.5 Flow cytometry 
CD25 BioLegend BC96 FITC Flow cytometry 
PD-1 BioLegend EH12.2.H7 APC-Cy7 Flow cytometry 
IL-4 BioLegend 8D4-8 PE Flow cytometry 
IL-17 BioLegend BL168 PE-Cy7 Flow cytometry 
RORt BioLegend AFKJS-9 PE Flow cytometry 
CD19 BD Bioscience HIB19 FITC Flow cytometry 
CD45RA BD Bioscience H100 FITC Flow cytometry 
T-bet BD Bioscience O4-46 PerCP-Cy5.5 Flow cytometry 
GATA3 BD Bioscience L50-823 PE-Cy7 Flow cytometry 
Bcl-6 BD Bioscience K112-91 PE Flow cytometry 
IFN- BD Bioscience B27 FITC Flow cytometry 
CD4 eBioScience RPA-T4 APC-eFluor780 Flow cytometry 
CD20 eBioscience L26 Alexa488 Immunohistofluorescence 
CD69 eBioscience FN50 PE Flow cytometry 
CCR7 eBioscience 3D12 PE Flow cytometry 
ICOS eBioscience ISA-3 PE-Cy7 Flow cytometry 
IL-21 eBioscience 3A3-N2 PE Flow cytometry 
Foxp3 eBioscience 236A/E7 PE Flow cytometry 
CXCR5 R&D Systems 51505.111 PE Flow cytometry 
CXCL13 R&D Systems 53610 APC 
Flow cytometry / 
Immunohistofluorescence 
     
     
 
 
 
